Microsoft shares fall 4% after coronavirus warning, wiping $50 billion off market value
- Shares of Microsoft Corp fell more than 4 per cent on Thursday after the company warned of weakness in PC business due to a hit to its supply chain from the coronavirus outbreak, echoing similar statements from Apple Inc and HP.
- Microsoft said on Wednesday its supply chain was returning to normal operations at a slower pace than anticipated and its Windows and Surface computers had been more negatively impacted than expected.
- The global stock markets have also taken a hit as investors grew cautious of the impact of the virus on global supply chains.
- Several Wall Street analysts expect other technology companies with heavy presence in China to soon come out with their own statements.
- Andrew MacMillen, an analyst with Nucleus Research, said that PC makers such as Dell Technologies Inc and Lenovo Group could be seeing some difficulties.
'Markets are trading on fear': Stocks tumble as coronavirus panic takes hold
- Stocks slumped on Thursday as investors braced for the novel coronavirus to escalate into a pandemic and hammer global growth.
- "Either COVID-19 is going to spread, making an untold number sick and killing many others, and economies will go into lockdown as supply chains are badly hit," Michael Every, senior Asia-Pacific strategist at RaboResearch, said in a research note on Thursday.
- "The market is understanding that the coronavirus outbreak will translate into significantly lower earnings and anemic global growth," Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said in a morning note.
- Stocks tumbled on Thursday as investors panicked at the growing prospect of the novel coronavirus becoming a pandemic and choking global growth.
Dangerous Coronavirus is 12x More Contagious Than MERS, Study Finds
- According to official data from the government of South Korea, coronavirus is 12 times more contagious than MERS and 3 times more than SARS in facilities with weak measures to combat against virus outbreaks.
- In a hospital in South Korea called “Cheongdo Daenam Hospital” that reported a local coronavirus outbreak, the reproductive rate of infection (R0) was 12.
- Already, the total number of coronavirus cases in South Korea has surpassed 1,600, and with a reproductive rate of infection, the number is expected to increase substantially in the near future.
- Ultimately, that led to local epidemics to breakout in South Korea, Iran, Italy, Thailand, and Japan, evolving the virus outbreak into a true global pandemic.
- The way coronavirus has crippled the economy of China and now Japan and South Korea is unprecedented, noticeably worse than MERS and SARS put together due to its high R0.
Stocks making the biggest moves after hours: Booking Holdings, Etsy, Nutanix and more
- Etsy — The e-commerce marketplace's stock soared 10% in extended trading after the company posted a double beat on earnings and revenue for the fourth quarter.
- The company's financials exceeded the expectations of analysts polled by Refinitiv, who estimated a loss of 69 cents per share on revenue of $342 million.
- Square — Shares of the financial services company were up 8% in extended trading after Square reported fourth-quarter earnings that beat analysts' estimates.
- Continental Resources — The oil and gas company's stock fell 16% in extended trading despite beating analyst expectations for fourth-quarter financial results.
- Box — The file-sharing service's stock was up 9% in extended trading after it reported fourth-quarter earnings that beat analysts' estimates.
- Carvana — The used car e-commerce platform saw its stock plunge 11% in extended trading after the company reported a wider loss than expected for the fourth quarter and fiscal-year guidance much lower than analysts estimated.
Peloton's stock is rising as fears over the spread of coronavirus could encourage customers to work out at home
- There are a select few stocks that seem to be rising in this uncertain time, however, one of which is the high-tech, at-home fitness company Peloton, best known for its $2,000 exercise bike.
- According to Needham analyst Laura Martin, the company could be in a position to benefit from the coronavirus crisis as consumers choose to work out at home rather than risk going to a gym or fitness studio.
- Gyms in China have already been forced to livestream their classes as consumers are forced to stay away from public places.
- A 29-year-old Londoner called Mary told The Guardian she had stopped going to the gym, despite the UK not currently being considered a high-risk area.
- Peloton, meanwhile, gives customers the ability to participate in boutique-style fitness classes without having to worry about being in a public space.
Air Canada was the world’s best airline stock two months ago. Now it’s the worst
- On Tuesday, the carrier extended the cancellation of all flights between Canada and China to April 10 over concerns about the virus known as Coved-19.
- — the biggest U.S. airline to China before American carriers temporarily suspended flights — withdrew its 2020 profit forecast late Monday, citing uncertainty from the virus.
- Last year, Air Canada won the global equity crown among airlines after rising 87 per cent with plans accelerate its global presence in leisure travel with the acquisition of tour operator Transat AT.
- Air Canada still has a positive longer-term outlook despite facing near-term pressure from coronavirus risk, Canadian Imperial Bank of Commerce analyst Kevin Chiang wrote in a report published Tuesday.
- The stock has 14 buy recommendations, two hold ratings and none of the analysts covering the company believes investors should sell the shares, according to data compiled by Bloomberg.
Lowe's shares fall as fourth-quarter sales fall short of estimates
- Lowe's shares fell Wednesday after the company reported mixed fourth-quarter results, with sales weaker than expected, and provided a disappointing forecast.
- In a news release, Ellison said the company is making strides in stores and with its overhaul of Lowes.com.
- Lowe's reported earnings a day after its rival, Home Depot, reported a strong fourth quarter that beat analysts' estimates.
- Home Depot said its sales benefited from a healthy housing market and a confident consumer and were fueled by a strong holiday season.
- Like Lowe's, Home Depot has been investing in improvements to its store and website.
- According to Refinitiv, analysts were expecting the retailer to earn between $6.34 and $6.92 per share.
- Along with efforts to revamp its online business, Lowe's named Marisa Thalberg its new chief brand and marketing officer in January.
S.Korea Coronavirus Cases Hit 1,250 but JPMorgan Warns of 10,000 Peak
- South Korea just announced 115 new confirmed cases of coronavirus, taking the total tally to a 1,261, as the epidemic spreads to more cities.
- The critical catalyst behind the coronavirus epidemic of South Korea, specifically Daegu, was the inability of the mayor’s office to identify the list of names that attended the cult church on the day the 31st coronavirus-infected individual visited the venue.
- The mayor of Daegu was heavily criticized for his lack of action when the epidemic first broke out and the inability to deal with the cult church in the matter governor Lee did this week.
- Based on the infection rate in Daegu, a lead analyst JPMorgan’s insurance arm wrote in a paper that the total number of coronavirus cases in South Korea can surge past 10,000 in the near-term.
The future of these 7 biotechs hinges on their ability to treat a silent liver disease and capture a $9.6 billion market. Here's exactly what investors should be watching for this year.
- Note: This list doesn't include big pharma companies with notable NASH readouts set for this year, such as Novo Nordisk's test of a diabetes drug against the liver disease.
- The French biotech Genfit will soon release results from a late-stage trial of about 1,000 patients testing its drug, elafibranor.
- It released data on February 24 from a mid-stage clinical trial, which showed that its lead drug, aldafermin had a noticeable clinical benefit in treating NASH compared to patients who got a placebo.
- And these positive results will have to be replicated again in a trial that would tee up an application for approval, although NGM's CEO David Woodhouse suggested that study could be quicker than previously expected given the recent positive data.
- An ongoing study testing the drug's efficacy in NASH is expected to produce results in the second half of 2020.
Apple may be working on a new pair of high-end headphones to rival Bose and Sennheiser — here's everything we know about them so far
- The Cupertino, California-based tech giant is rumored to be working on a pair of high-end, over-ear headphones that would rival the likes of products made by Bose and Sennheiser.
- . Kuo has described the headphones as being "high-end," while Bloomberg wrote that they will compete with "pricey" models from firms like Bose and Sennheiser.
- If Apple is launching a new pair of headphones to compete with such models, they'll likely be far more expensive than the $250 AirPods Pro. The leaked Target listing discovered by Prosser also suggests these new headphones could cost $400.
- Bloomberg also reported that the AirPods' quick-pairing feature would likely make it to the company's over-ear headphones as well.
- When Apple debuted the HomePod in 2017, it positioned it as being a premium alternative to voice-activated speakers like Amazon's Echo and the Google Home for customers who prioritize high-end audio.